莫桑比克、巴基斯坦和印度社区层面子痫前期干预(CLIP)整群随机试验的个体参与者水平荟萃分析
干预组接受社区参与和社区卫生工作者主导的移动健康支持的早期检测、初始治疗和转诊。
要点
- 社区层面干预未减少孕产妇或围产期不良结局复合终点。
- 干预组主要结局发生率为24%,对照组为22%,差异无统计学意义。
- 未发生干预相关严重不良事件,社区内治疗不良事件罕见。
核心结论
- CLIP社区层面干预未降低不良妊娠结局复合终点。
- 未来社区干预应扩大社区卫生工作者队伍、评估通用信息传递并加强卫生系统建设。
研究设计与样本
- 个体参与者水平荟萃分析,汇总莫桑比克、巴基斯坦和印度三项CLIP整群随机对照试验(2014-17年)。
- 纳入所有 consenting 且试验结束时完成妊娠随访的参与者;采用多水平模型分析,调整母亲年龄、产次、教育程度(固定效应)及国家和整群(随机效应)。
主要发现
- 1255例(6%)被转诊至综合急诊产科护理机构,其中864例(82%)接受转诊。
- 未发生干预相关严重不良事件;社区内甲基多巴治疗不良事件1例(2%,仅印度),硫酸镁社区内治疗及转运途中无不良事件。
临床怎么用
- 该社区层面干预方案未显示可减少不良妊娠结局,不支持直接推广用于改善结局。
- 未来社区干预需考虑扩大社区卫生工作者队伍、采用通用而非条件特异性信息传递,并加强卫生系统建设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To overcome the three delays in triage, transport and treatment that underlie adverse pregnancy outcomes, we aimed to reduce all-cause adverse outcomes with community-level interventions targeting women with pregnancy hypertension in three low-income countries. METHODS: In this individual participant-level meta-analysis, we de-identified and pooled data from the Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised controlled trials in Mozambique, Pakistan, and India, which were run in 2014-17. Consenting pregnant women, aged 12-49 years, were recruited in their homes. Clusters, defined by local administrative units, were randomly assigned (1:1) to intervention or control groups. The control groups continued local standard of care. The intervention comprised community engagement and existing community health worker-led mobile health-supported early detection, initial treatment, and hospital referral of women with hypertension. For this meta-analysis, as for the original studies, the primary outcome was a composite of maternal or perinatal outcome (either maternal, fetal, or neonatal death, or severe morbidity for the mother or baby), assessed by unmasked trial surveillance personnel. For this analysis, we included all consenting participants who were followed up with completed pregnancies at trial end. We analysed the outcome data with multilevel modelling and present data with the summary statistic of adjusted odds ratios (ORs) with 95% CIs (fixed effects for maternal age, parity, maternal education, and random effects for country and cluster). This meta-analysis is registered with PROSPERO, CRD42018102564. FINDINGS: Overall, 44 clusters (69 330 pregnant women) were randomly assigned to intervention (22 clusters [36 008 pregnancies]) or control (22 clusters [33 322 pregnancies]) groups. 32 290 (89·7%) pregnancies in the intervention group and 29 698 (89·1%) in the control group were followed up successfully. Median maternal age of included women was 26 years (IQR 22-30). In the intervention clusters, 6990 group and 16 691 home-based community engagement sessions and 138 347 community health worker-led visits to 20 819 (57·8%) of 36 008 women (of whom 11 095 [53·3%] had a visit every 4 weeks) occurred. Blood pressure and dipstick proteinuria were assessed per protocol. Few women were eligible for methyldopa for severe hypertension (181 [1%] of 20 819) or intramuscular magnesium sulfate for pre-eclampsia (198 [1%]), of whom most accepted treatment (162 [89·5%] of 181 for severe hypertension and 133 [67·2%] of 198 for pre-eclampsia). 1255 (6%) were referred to a comprehensive emergency obstetric care facility, of whom 864 (82%) accepted the referral. The primary outcome was similar in the intervention (7871 [24%] of 32 290 pregnancies) and control clusters (6516 [22%] of 29 698; adjusted OR 1·17, 95% CI 0·90-1·51; p=0·24). No intervention-related serious adverse events occurred, and few adverse effects occurred after in-community treatment with methyldopa (one [2%] of 51; India only) and none occurred after in-community treatment with magnesium sulfate or during transport to facility. INTERPRETATION: The CLIP intervention did not reduce adverse pregnancy outcomes. Future community-level interventions should expand the community health worker workforce, assess general (rather than condition-specific) messaging, and include health system strengthening. FUNDING: University of British Columbia, a grantee of the Bill & Melinda Gates Foundation.
引用
- von Dadelszen P, Bhutta ZA, Sharma S, et al. The Community-Level Interventions for Pre-eclampsia (CLIP) cluster randomised trials in Mozambique, Pakistan, and India: an individual participant-level meta-analysis. Lancet. 2020. PMID: 32828187. doi:10.1016/S0140-6736(20)31128-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。